Principal Investigator
Izidore Lossos
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20231248
Clinical Trial Summary
A Phase III, Open-Label, Multicenter Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647